Skip to content
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Search
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Advertise
NEWSLETTER
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
About
Contact
About
Contact
Advertise
nEWSLETTER
Search
Search
Resolution Therapeutics pos...
Circular Genomics partners ...
Viome acquires Sōlaria Biō ...
Humanaut Health expands wit...
Daiichi Sankyo, AstraZeneca...
Resolution Therapeutics pos...
Circular Genomics partners ...
Viome acquires Sōlaria Biō ...
Humanaut Health expands wit...
Daiichi Sankyo, AstraZeneca...
IPF
Biotech
FDA to review inhaled drug for deadly lung scarring
Biotech
United Therapeutics unveils major lung, heart data
Biotech
Rentosertib puts aging clocks to the clinical test
Biotech
AI-designed IPF drug advances to Phase III
Biotech
Investment
Investment
Tribune raises €37m to advance fibrosis-targeting therapeutics
Biotech
Investment
Investment
Refoxy lands €9.1m to advance FOXO3 therapeutics for age-related diseases
Biotech
Insilico’s IPF drug demonstrated ‘clinically meaningful’ benefits in trial
Biotech
Investment
Investment
Rubedo lands $40m to advance senescence-targeting therapeutics into clinical trials
Biotech
Insilico announces positive topline results for IPF treatment
The latest longevity science, investment, innovation and insight, delivered every morning.
First Name
(Required)
Email Address
(Required)
Contact Source
Unlock Longevity Biotech Report for FREE
$617BN - Annual global revenue by 2045
$30BN+ - Invested in under 2 years
3,036 - Therapeutics individually assessed
Access full report